GlassScriptPhysician profile
Michael D Gilmore
NPI 1013961283
$3,584.90
in general payments reported to CMS, 2019-2025
8 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,649 · 2021: $102 · 2022: $281 · 2023: $170 · 2024: $39.15 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $809 · Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $808.99 |
| Food and Beverage | $743.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,649.01 | 2019 | |
| Vericel Corporation | $1,208.59 | 2022-2025 | Maci |
| Stimwave Technologies Incorporated | $364.66 | 2021-2022 | |
| Smith+Nephew, INC. | $166.77 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Cerapedics INC. | $126.69 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Mml US, INC. | $31.73 | 2023-2025 | Reactiv8 |
| Nalu Medical, INC. | $22.23 | 2025 | Nalu Neurostimulation System |
| Curonix LLC | $15.22 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.